Tuesday, April 25, 2017

News Highlights: Top Company News of the Day

Ernst & Young demanded the Dublin drugmaker adjust its accounting for the multiple sclerosis drug Tysabri after Perrigo sold the royalty rights in a ...

more here

No comments:

Post a Comment